149 related articles for article (PubMed ID: 32767333)
1. Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma.
Gulli F; Marino M; Napodano C; Pocino K; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8067-8074. PubMed ID: 32767333
[TBL] [Abstract][Full Text] [Related]
2. Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.
Basile U; Marino M; Gragnani L; Napodano C; Gulli F; Pocino K; Lorini S; Santini SA; Basile V; Miele L; Zignego AL; Rapaccini GL
J Immunol Methods; 2020 Jan; 476():112687. PubMed ID: 31669506
[TBL] [Abstract][Full Text] [Related]
3. A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders.
Basile U; Gulli F; Isgrò MA; Napodano C; Pocino K; Santini SA; Gragnani L; Conti L; Rossi E; Cordone I; Zignego AL; Rapaccini GL; Cigliana G; Berruti F; Todi L; Marino M; Di Stasio E
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4293-4302. PubMed ID: 31173301
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders.
Basile U; Napodano C; Pocino K; Barini A; Marino M; Santini SA; Barini A; Stefanile A; Basile V; Callà CA; Cattani P; Gasbarrini A; Rapaccini GL; Gulli F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8506-8514. PubMed ID: 31646582
[TBL] [Abstract][Full Text] [Related]
5. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia.
De Vita S; Sansonno D; Dolcetti R; Ferraccioli G; Carbone A; Cornacchiulo V; Santini G; Crovatto M; Gloghini A; Dammacco F; Boiocchi M
Blood; 1995 Sep; 86(5):1887-92. PubMed ID: 7655017
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
Terrier B; Chaara W; Dufat L; Geri G; Rosenzwajg M; Musset L; Sène D; Saadoun D; Six A; Klatzmann D; Cacoub P
Autoimmun Rev; 2014 Mar; 13(3):319-26. PubMed ID: 24220267
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
[TBL] [Abstract][Full Text] [Related]
11. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
[TBL] [Abstract][Full Text] [Related]
12. Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders.
Libra M; Indelicato M; De Re V; Zignego AL; Chiocchetti A; Malaponte G; Dianzani U; Nicoletti F; Stivala F; McCubrey JA; Mazzarino MC
Cancer Biol Ther; 2005 Nov; 4(11):1192-4. PubMed ID: 16177564
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
14. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
15. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
17. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
18. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.
De Re V; De Vita S; Marzotto A; Rupolo M; Gloghini A; Pivetta B; Gasparotto D; Carbone A; Boiocchi M
Blood; 2000 Nov; 96(10):3578-84. PubMed ID: 11071657
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
Fognani E; Giannini C; Piluso A; Gragnani L; Monti M; Caini P; Ranieri J; Urraro T; Triboli E; Laffi G; Zignego AL
PLoS One; 2013; 8(5):e62965. PubMed ID: 23650540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
